Ignite Creation Date:
2025-12-24 @ 7:36 PM
Ignite Modification Date:
2025-12-25 @ 5:16 PM
Study NCT ID:
NCT00465803
Status:
COMPLETED
Last Update Posted:
2014-07-24
First Post:
2007-04-23
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension
Sponsor:
Alcon Research
Organization:
Study Overview
Official Title:
Compliance Study Comparing DuoTrav to TRAVATAN Plus Timolol Using the Dosing Aid
Status:
COMPLETED
Status Verified Date:
2012-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess patient compliance with DuoTrav versus concomitant administration of Timolol 0.5% plus TRAVATAN in patients with open-angle glaucoma or ocular hypertension.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: